Yolanda S. Kap 1, Marjan van Meurs 1, Nikki van Driel 1, Gerrit Koopman 1, Marie-Jose Melief 1, Herbert P.M. Brok 1, Jon D. Laman 1 and Bert A. ’t Hart 1*
1 Department of Immunobiology (YSK,NVD,BATH), Virology (GK), and Animal Science (HPMB), Biomedical Primate Research Centre, Rijswijk, The Netherlands, and Department of Immunology (YSK,MVM,M-JM,JDL,BATH) and Multiple Sclerosis Centre ErasMS (YSK,MVM,M-JM,JDL,BATH), Erasmus Medical Centre, Rotterdam, The Netherlands
* To whom correspondence should be addressed. E-mail: hart{at}bprc.nl.
Submitted on April 17, 2000
Accepted on 18 August 2009
 |
Abstract |
|---|
Non-human primates (NHP) offer valuable animal models for basic research into human diseases and for the preclinical validation of new therapeutics. Detailed in situ examination of the involved cell types using immunohistochemistry is often hampered by the lack of cross-reactive antibodies. In the current study, we have tested a large panel of monoclonal antibodies raised against human leukocyte differentiation and activation markers for cross-reactivity on cryosections of lymphoid tissue from six NHP species. In total, we have tested 130 antibodies against 69 antigens expressed in tissues from one great ape species (chimpanzee/Pan troglodytes), two Old World species (rhesus macaque/Macaca mulatta and cynomolgus macaque/Macaca fascicularis), and three New World species (common marmoset/Callithrix jacchus, cotton-top tamarin/Saguinus oedipus, and owl monkey/Aotus triviogatus). We have found a large panel of cross-reactive antibodies: 93 of 102 (91%) in chimpanzee, 97 of 125 (78%) in rhesus macaque, 70 of 109 (64%) in cynomolgus macaque, 69 of 116 (60%) in common marmoset, 40 of 81 (49%) in cotton-top tamarin, and 35 of 80 (44%) in owl monkey. Availability of a reliable panel of cross-reactive markers is important to gain further insight into immunological processes in disease-affected tissues from NHP species.
Key Words:
immunology, toxicology, pathology, arthritis, multiple sclerosis, HIV-SIV
